CBX7 and meningioma: To determine the clinical significance of the CBX7/c-MYC/LDHA axis in meningioma, immunohistochemistry was performed in meningioma patient samples with different malignancy grades to detect the expression levels of CBX7, Ki-67, c-MYC, and LDHA.